Timothée Olivier, MD· @Timothee_MD · X·· 2 天前评分90
正文 · 原文
#ESMO26
NATALEE 6-y OS results are online, ahead of today's presentation (2:25 pm).
OS HR 0.809 (95% CI 0.661–0.989); 6-y OS: 91.9% vs 89.7% (Δ2.1%). Nominal 1-sided P=.019.
What remains key? 👉 Post-protocol care!
See why in my talk at @MDAnderson_ES 👇
1544 浏览 · 19 赞 · 4 转发 · 0 回复
会议摘要
LBA25按 Proffered paper 1: Breast cancer, early and advanced stage 对上
Adjuvant ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2− early breast cancer (EBC): NATALEE 6-y overall survival (OS) and efficacy outcomes
https://esmocongress.esmo.org来源：Timothée Olivier, MD · x.com